Recombinant multi-species KMT2A/MLL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KMT2A/MLL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
The Alternative Names of target: 6430520K01,ALL-1,ALL1,All1,CXXC-type zinc finger protein 7,CXXC7,Cxxc7,Cysteine methyltransferase KMT2A,GAS7,HRX,HTRX,HTRX1,Histone-lysine N-methyltransferase 2A,KMT2A,Kmt2a,Lysine N-methyltransferase 2A,MLL,MLL1,MLL1A,Mll,Mll1,Myeloid/lymphoid or mixed-lineage leukemia,Myeloid/lymphoid or mixed-lineage leukemia protein 1,TRX1,Trithorax-like protein,WDSTS,Zinc finger protein HRX,all-1,mKIAA4050
Go
to KMT2A/MLL products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T25462-Ag-1/ GM-Tg-hg-T25462-Ag-2 | Human KMT2A/MLL protein | Human |
| GM-Tg-rg-T25462-Ag-1/ GM-Tg-rg-T25462-Ag-2 | Rat KMT2A/MLL protein | Rat |
| GM-Tg-mg-T25462-Ag-1/ GM-Tg-mg-T25462-Ag-2 | Mouse KMT2A/MLL protein | Mouse |
| GM-Tg-cynog-T25462-Ag-1/ GM-Tg-cynog-T25462-Ag-2 | Cynomolgus/Rhesus macaque KMT2A/MLL protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T25462-Ag-1/ GM-Tg-felg-T25462-Ag-2 | Feline KMT2A/MLL protein | Feline |
| GM-Tg-cang-T25462-Ag-1/ GM-Tg-cang-T25462-Ag-2 | Canine KMT2A/MLL protein | Canine |
| GM-Tg-bovg-T25462-Ag-1/ GM-Tg-bovg-T25462-Ag-2 | Bovine KMT2A/MLL protein | Bovine |
| GM-Tg-equg-T25462-Ag-1/ GM-Tg-equg-T25462-Ag-2 | Equine KMT2A/MLL protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T25462-Ag-1/ GM-Tg-hg-T25462-Ag-2;
GM-Tg-rg-T25462-Ag-1/ GM-Tg-rg-T25462-Ag-2;
GM-Tg-mg-T25462-Ag-1/ GM-Tg-mg-T25462-Ag-2; GM-Tg-cynog-T25462-Ag-1/ GM-Tg-cynog-T25462-Ag-2; GM-Tg-felg-T25462-Ag-1/ GM-Tg-felg-T25462-Ag-2; GM-Tg-cang-T25462-Ag-1/ GM-Tg-cang-T25462-Ag-2; GM-Tg-bovg-T25462-Ag-1/ GM-Tg-bovg-T25462-Ag-2; GM-Tg-equg-T25462-Ag-1/ GM-Tg-equg-T25462-Ag-2 |
| Products Name | KMT2A/MLL protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | KMT2A/MLL |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KMT2A/MLL protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.